EcoDrugPlus

Protein Kinase C Iota

Ensembl ID : ENSFCAG00000026908
Gene Symbol: PRKCI
5 Cross references
226 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSFCAG00000009472
Gene Symbol: PRKCQ
5 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSFCAG00000006209
Gene Symbol: PRKCZ
5 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSFCAG00000014491
Gene Symbol: PRKD1
5 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSFCAG00000015768
Gene Symbol: PRKD3
5 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSFCAG00000025137
Gene Symbol: PRKACA
5 Cross references
288 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSFCAG00000027890
Gene Symbol: PRKACB
5 Cross references
304 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSFCAG00000011374
Gene Symbol: PRKDC
5 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSFCAG00000022635
Gene Symbol: PPP3CA
5 Cross references
232 Possible Orthologues:

Protein Phosphatase, Mg2+/mn2+ Dependent 1f

Ensembl ID : ENSFCAG00000002630
Gene Symbol: PPM1F
5 Cross references
214 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSFCAG00000014619
Gene Symbol: PTK2
5 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSFCAG00000014420
Gene Symbol: PTK2B
5 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).